Cargando…

Phase II study of induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil followed by radioimmunotherapy with cetuximab and intensity-modulated radiotherapy in combination with a carbon ion boost for locally advanced tumors of the oro-, hypopharynx and larynx

PURPOSE: This phase II trial was designed to evaluate efficacy and safety of a highly intensified therapy in locally advanced squamous cell carcinoma of the oro-, hypopharynx and larynx. METHODS: In this prospective, mono-centric, open-label, non-randomized phase II trial the single treatment arm co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hauswald, H., Jensen, A.D., Krauss, J., Haselmann, R., Lossner, K., Hartmann, S., Windemuth-Kieselbach, C., Münter, M.W., Debus, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199783/ https://www.ncbi.nlm.nih.gov/pubmed/30370340 http://dx.doi.org/10.1016/j.ctro.2018.09.005

Ejemplares similares

Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx - TPF-C-HIT
por: Jensen, Alexandra D, et al.
Publicado: (2011)

RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab
por: Jensen, Alexandra D, et al.
Publicado: (2010)

Multicentre study on resection margins in carcinoma of the oral cavity, oro-hypopharynx and larynx
por: Barzan, Luigi, et al.
Publicado: (2022)

Larynx organ preservation in subjects with hypopharynx-larynx cancer
por: Conticello, S, et al.
Publicado: (2010)

Treatment of malignant sinonasal tumours with intensity-modulated radiotherapy (IMRT) and carbon ion boost (C12)
por: Jensen, Alexandra D, et al.
Publicado: (2011)

Fatty Tumour of the Hypopharynx Obstructing the Larynx
por: Fraser, J. S.
Publicado: (1916)

Combined treatment of malignant salivary gland tumours with intensity-modulated radiation therapy (IMRT) and carbon ions: COSMIC
por: Jensen, Alexandra D, et al.
Publicado: (2010)

Role of neoadjuvant chemotherapy in advanced carcinoma of the hypopharynx and larynx
por: Joshi, Poonam, et al.
Publicado: (2017)

Plasma Cell Mucositis of Oro- and Hypopharynx: A Case Report
por: Puvanendran, Mark, et al.
Publicado: (2012)

Lymphoepithelial Carcinoma of Larynx and Hypopharynx: A Rare Clinicopathological Entity
por: Faisal, Muhammad, et al.
Publicado: (2020)

Carcinoma of the posterior wall of the hypopharynx: surgical treatment with larynx preservation
por: Başaran, Bora, et al.
Publicado: (2020)

Radioimmunotherapy for mantle cell lymphoma: 5-year follow-up of 90 patients from the international RIT registry
por: Hohloch, Karin, et al.
Publicado: (2020)

Treatment of non-small cell lung cancer with intensity-modulated radiation therapy in combination with cetuximab: the NEAR protocol (NCT00115518)
por: Jensen, AD, et al.
Publicado: (2006)

Treatment of Advanced Carcinoma of the Larynx and Hypopharynx with Laser Followed by External Radiotherapy
por: Varghese, Lalee, et al.
Publicado: (2017)

Thyroid gland invasion in advanced squamous cell carcinoma of the larynx and hypopharynx()()
por: Mangussi-Gomes, João, et al.
Publicado: (2016)

Unusual metastasis of papillary thyroid carcinoma to larynx and hypopharynx a case report
por: Varghese, Bipin T, et al.
Publicado: (2003)

Gene and miRNA expression changes in squamous cell carcinoma of larynx and hypopharynx
por: Nair, Jayalakshmi, et al.
Publicado: (2015)

The importance of pre-epiglottis space invasion in the treatment planning of larynx and hypopharynx cancer
por: Rapoport, Abrão, et al.
Publicado: (2015)

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial
por: Jensen, Alexandra D, et al.
Publicado: (2012)

Simultaneous integrated boost therapy of carcinoma of the hypopharynx/larynx with and without flattening filter - a treatment planning and dosimetry study
por: Dobler, Barbara, et al.
Publicado: (2017)

Persistent Tracheostomy after Organ Preservation Protocol in Patients Treated for Larynx and Hypopharynx Cancer
por: Chiesa Estomba, Carlos Miguel, et al.
Publicado: (2017)

Clinicopathological and immunohistochemical analysis of spindle cell carcinoma of the larynx or hypopharynx: A report of three cases
por: ZHENG, YI, et al.
Publicado: (2014)

The impact of elevated C-reactive protein level on the prognosis for oro-hypopharynx cancer patients treated with radiotherapy
por: Katano, Atsuto, et al.
Publicado: (2017)

Feasibility of Induction Docetaxel, Cisplatin, 5-Fluorouracil, Cetuximab (TPF-C) Followed by Concurrent Cetuximab Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Charalambakis, Nikolaos, et al.
Publicado: (2013)

Functional Larynx Preservation in Patients With Locally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx Treated With Induction Chemotherapy vs. Concurrent Chemoradiation Alone
por: Nehlsen, Anthony D, et al.
Publicado: (2021)

IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial
por: Jensen, Alexandra D, et al.
Publicado: (2012)

Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux(® )and particle therapy]
por: Jensen, Alexandra D, et al.
Publicado: (2011)

Prognostic Potential of the Expression of Podoplanin (D2-40) Within Cells of Squamous Cell Carcinoma of the Larynx and Hypopharynx
por: Voelker, Hans-Ullrich, et al.
Publicado: (2020)

Docetaxel-Cisplatin-Fluorouracil Induction Chemotherapy for Larynx Preservation in Patients with Locally Advanced Hypopharyngeal Cancer: Predictive Factors of Oncologic and Functional Outcomes
por: Mattei, Pierre, et al.
Publicado: (2023)

Dynamic contrast-enhanced magnetic resonance imaging for pretreatment prediction of early chemo-radiotherapy response in larynx and hypopharynx carcinoma
por: Guo, Wei, et al.
Publicado: (2016)

Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT) – phase I/II trial: study protocol
por: Combs, Stephanie E, et al.
Publicado: (2006)

Lymphangiosis carcinomatosa in squamous cell carcinomas of larynx and hypopharynx – value of conventional evaluation and additional immunohistochemical staining of D2-40
por: Völker, Hans-Ullrich, et al.
Publicado: (2009)

Optimized Generation of Primary Human Epithelial Cells from Larynx and Hypopharynx: A Site-Specific Epithelial Model for Reflux Research
por: Mo, Ting-Ting, et al.
Publicado: (2019)

Time between Diagnosis and Treatment of Hypopharynx and Larynx Cancer: Are Longer Delays Associated with Higher Discrepancy between Clinical and Pathological Staging?
por: Santos, Mariline, et al.
Publicado: (2021)

Lymphoepithelial Cyst of the Hypopharynx
por: Kawaida, Masahiro, et al.
Publicado: (1995)

Fibrovascular polyp of the hypopharynx
por: Al-Swiahb, Jamil N., et al.
Publicado: (2008)

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Hypopharynx, Larynx, Trachea and Parapharyngeal Space
por: Zidar, Nina, et al.
Publicado: (2022)

Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone: Analysis of the Austrian head and neck cancer registry of the AGMT
por: Magnes, Teresa, et al.
Publicado: (2021)

Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: Long-term results of the randomized controlled phase II PARC trial
por: Liermann, Jakob, et al.
Publicado: (2022)

Structured oropharynx, hypopharynx and larynx assessment during routine esophagogastroduodenoscopy improves detection of pre- and early cancerous lesions: a multicenter, comparative study
por: Huelsen, Alexander, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_du5jqrm60mtvuk9kq0k0949e2k